Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma informs about press release

Date: 28-05-2024
Natco Pharma has informed that it enclosed Copy of News Paper Publication of the Audited Financial Results of the Company for the Quarter and Year ended March 31, 2024.

The above information is a part of company’s filings submitted to BSE.